Nisa Investment Advisors
RAIN

Nisa Investment Advisors’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Nisa Investment Advisors’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,286
Closed -$214 – 2345
2021
Q3 		$214 Buy
+14,286
New +$244K ﹤0.01% 1382

Other funds holding RAIN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Nisa Investment Advisors's RAIN Position: Q4 2021 in Review

Nisa Investment Advisors sold out of Rain Oncology Inc. Common Stock (RAIN) in Q4 2021, closing a stake of 14,286 shares — an estimated $214 sold.

Nisa Investment Advisors first reported a position in RAIN in Q3 2021 and held it in 1 quarter. The position peaked at $214 in Q3 2021. 41 funds tracked by Wall St. Rank hold RAIN as of Q4 2021.

  • Nisa Investment Advisors reported no remaining Rain Oncology Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 14,286 Rain Oncology Inc. Common Stock shares in Q4 2021, an estimated $214.
  • Nisa Investment Advisors first reported a position in Rain Oncology Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Nisa Investment Advisors's Rain Oncology Inc. Common Stock position peaked at $214 in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q4 2021.

Based on Nisa Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.